RxDoctor Payments DataLook up a doctor →

George Chrysant, MD

Interventional Cardiology · Oklahoma City, OKNPI 1093719015

Payments from drug & device makers

$873,361in general payments, 2019–2025

Across 1,843 payments — averaging $473.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$255K
  • Medtronic$151K
  • Abbott$114K
  • Boston Scientific$108K
  • Shockwave Medical, Inc$79K
  • Heartflow, Inc.$44K
  • plus $123K from 38 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Penumbra, Inc.195$255,091
Medtronic(2 entities)516$150,874
Abbott275$114,008
Boston Scientific312$107,835
Shockwave Medical, Inc190$79,132
Heartflow, Inc.35$43,713
Acarix USA Inc.5$40,997
Philips North America LLC105$40,005
M.a. Med Alliance S.A.4$23,360
Biotronik Inc.16$6,341
Edwards Lifesciences48$3,395
Cordis US CORP.4$1,688
Recor Medical Inc18$1,625
Abiomed20$984
Bard Peripheral Vascular, Inc.6$882
Sirtex Medical Inc1$550
Siemens Medical Solutions USA, Inc.7$439
W. L. Gore & Associates, Inc.5$402
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)15$260
Surmodics, Inc.9$233
E.r. Squibb & Sons, L.L.C.10$166
Imperative Care, Inc1$163
Asahi Intecc USA, Inc.2$141
Terumo Medical Corporation1$125
Actelion Pharmaceuticals US, Inc.6$115
Chiesi USA, Inc.5$99
Kestra Medical Technology Services, Inc.3$77
Amgen4$77
GE HealthCare1$63
Pfizer4$58
Atricure, Inc.1$54
Cvrx, Inc.2$51
Tactile Systems Technology Inc2$44
Merck2$41
Johnson & Johnson2$40
AstraZeneca2$38
Cagent Vascular Inc1$38
Stryker1$36
Boehringer Ingelheim2$30
Cleerly, Inc.1$29
BD1$23
Novartis1$16
Cook Medical LLC1$14
Irhythm Technologies, Inc.1$12

How this compares

$873,361 in reported general payments places this provider in the 95th percentile of 110 interventional cardiology providers in Oklahoma.

See all interventional cardiology providers in Oklahoma →

Medicare billing

Part B allowed, 2024
$413,595
Medicare patients
1,745
Services billed
4,037

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Oklahoma City

See the full list for Oklahoma →

Where these figures come from

Is this you, or does something look wrong? →